COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02467335
Recruitment Status : Completed
First Posted : June 10, 2015
Last Update Posted : September 25, 2017
Information provided by (Responsible Party):
ViiV Healthcare

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 3, 2015
Actual Study Completion Date : October 3, 2015